AVN-944

AVN-944 Suppliers list
Company Name: Amadis Chemical Company Limited
Tel: 571-89925085
Email: sales@amadischem.com
Products Intro: Product Name:[(1s)-2-cyano-1-methyl-ethyl] N-[(1r)-1-[3-[(3-methoxy-4-oxazol-5 -yl-phenyl)carbamoylamino]phenyl]ethyl]carbamate
CAS:501345-02-4
Purity:0.97 Package:mgs,gs,kgs Remarks:A871653
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel: 021-50182298 021-50180596
Email: sales@boylechem.com
Products Intro: Product Name:AVN-944
CAS:501345-02-4
Company Name: Changzhou Chenhong Biotechnology Co., Ltd.  
Tel: 0519-85788828 13775037613
Email: sales@chemrenpharm.com
Products Intro: Product Name:AVN944
CAS:501345-02-4
Purity:99% Package:50mg;100mg;250mg;500mg;1g;5g
Company Name: Shanghai Zeye Biotechnology Co., Ltd.  
Tel: 021-61998551 13122364865
Email: sale1@shzysw.net
Products Intro: Product Name:AVN-944
Purity:99.9% Package:2mg/
Company Name: Shanghai tingchong biology science and technology co., ltd  
Tel: 18964309092 18964309092
Email: 2769493375@qq.com
Products Intro: Product Name:AVN944
CAS:501345-02-4
Purity:98%+HPLC Package:1g;5g;10g;50g;100g
AVN-944 Basic information
Product Name:AVN-944
Synonyms:AVN-944;[(1s)-2-cyano-1-methyl-ethyl] N-[(1r)-1-[3-[(3-methoxy-4-oxazol-5 -yl-phenyl)carbamoylamino]phenyl]ethyl]carbamate
CAS:501345-02-4
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
AVN-944 Structure
AVN-944 Chemical Properties
Safety Information
MSDS Information
AVN-944 Usage And Synthesis
UsesAVN-944 is a novel inosine monophosphate dehydrogenase (IMPDH) inhibitor. It has antiproliferative effects and might be combined with other agents for treatment of human prostate cancer.This compound is suitable for pyruvate dehydrogenase (PDH) related research.
Enzyme inhibitorThis orally available antineoplastic agent (FW = 310.36 g/mol; CAS 297730-17-7), also known as VX-944 and (R) -1-cyanobutan-2-yl- (S) -1- (3- (3- (3-methoxy-4- (oxazol-5-yl) phenyl) ureido) phenyl) ethyl) carbamate, inhibits inosine 5’-monophosphate dehydrogenase (IMPDH), the enzyme catalyzing the conversion of IMP into XMP, leading to the biosynthesis of GMP, GDP, GTP, and ultimately dGTP. IMPDH is overexpressed in some cancer cells, particularly in hematological malignancies, and AVN944 appears to have a selective cytotoxic effect on cancer cells. Reduction of GTP in normal cells results in a temporary slowing of cell growth only. AVN944 treatment results in dose-dependent cell growth inhibition in all studied prostate cancer cells, independently of their androgen sensitivity . AVN944 treatment arrests LNCaP cells in G1-phase and and androgen- independent 22Rv1, DU145 and PC-3 cells in S-phase. AVN-944 treatment leads to the rapid disappearance of nucleostemin, a positive regulator of cell proliferation that is highly expressed in a variety of stem cells, tumors, and tumor cell lines.
AVN-944 Preparation Products And Raw materials
Tag:AVN-944(501345-02-4) Related Product Information